POWDERMED
PowderMed developed vaccines for the treatment of chronic infectious diseases and cancer. The company used DNA coated gold particles delivered by a needle-free injection device to stimulate a powerful and specific T cell immune response.
POWDERMED
Industry:
Health Care Medical Therapeutics
Founded:
2004-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Contact:
+441865501500
Total Funding:
20 M GBP
Similar Organizations
CorneaCare
Personalized dry eye treatment delivered and monitored.
Verdel Instruments
Verdel Instruments has developed new two-dimensional mass spectrometry (2DMS) technology.
Current Employees Featured

Founder
![]()

Investors List
Abingworth
Abingworth investment in Series A - PowderMed
Advent Venture Partners
Advent Venture Partners investment in Series A - PowderMed
![]()
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series A - PowderMed
![]()
SV Health Investors
SV Health Investors investment in Series A - PowderMed
Schroder Ventures
Schroder Ventures investment in Series A - PowderMed